# AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)

> **NCT05556603** · — · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 7062 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05556603
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-28
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 7062 (ESTIMATED)
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05556603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05556603, "AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05556603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*